TransAct Technologies' Q2 sales beat expectations

Reuters
Aug 07, 2025
TransAct Technologies' <a href="https://laohu8.com/S/QTWO">Q2</a> sales beat expectations

Overview

  • TransAct Q2 net sales rise 19% yr/yr, beating analyst expectations

  • Adjusted EBITDA for Q2 beats estimates, reflecting improved profitability

  • Co acquires perpetual license for BOHA! software source code

Outlook

  • Company expects full-year 2025 net sales between $49 mln and $53 mln

  • TransAct forecasts adjusted EBITDA for 2025 to be $0 to $1.5 mln

Result Drivers

  • CASINO AND GAMING SALES - Casino and gaming sales increased 42% yr/yr and 14% sequentially, contributing to revenue growth

  • FST REVENUE - FST recurring revenue rose 7% yr/yr, reflecting progress in sales strategies

  • SOURCE CODE ACQUISITION - Acquisition of BOHA! software source code expected to enhance platform capabilities

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$13.80 mln

$12.60 mln (1 Analyst)

Q2 EPS

-$0.01

Q2 Net Income

-$143,000

Q2 Adjusted EBITDA

Beat

$478,000

-$87,000 (1 Analyst)

Q2 Gross Margin

48.2%

Q2 Operating Income

-$258,000

Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the computer hardware peer group is "buy"

  • Wall Street's median 12-month price target for TransAct Technologies Inc is $5.00, about 22.8% above its August 5 closing price of $3.86

Press Release: ID:nBw28FnNwa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10